376 related articles for article (PubMed ID: 23414543)
21. Use of oral proton pump inhibitors is not associated with harm in patients with chronic heart failure in an ambulatory setting.
Oudit GY; Bakal JA; McAlister FA; Ezekowitz JA
Eur J Heart Fail; 2011 Nov; 13(11):1211-5. PubMed ID: 21831912
[TBL] [Abstract][Full Text] [Related]
22. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada.
Rahme E; Barkun A; Nedjar H; Gaugris S; Watson D
Am J Gastroenterol; 2008 Apr; 103(4):872-82. PubMed ID: 18371130
[TBL] [Abstract][Full Text] [Related]
23. Immediate and Delayed Hypersensitivity Reactions to Proton Pump Inhibitors: Evaluation and Management.
Otani IM; Banerji A
Curr Allergy Asthma Rep; 2016 Mar; 16(3):17. PubMed ID: 26810177
[TBL] [Abstract][Full Text] [Related]
24. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor.
Stockl KM; Le L; Zakharyan A; Harada AS; Solow BK; Addiego JE; Ramsey S
Arch Intern Med; 2010 Apr; 170(8):704-10. PubMed ID: 20421557
[TBL] [Abstract][Full Text] [Related]
25. Management of Hypersensitivity Reactions to Proton Pump Inhibitors: A Retrospective Experience.
Kepil Özdemir S; Öner Erkekol F; Ünal D; Büyüköztürk S; Gelincik A; Dursun AB; Karakaya G; Bavbek S
Int Arch Allergy Immunol; 2016; 171(1):54-60. PubMed ID: 27838693
[TBL] [Abstract][Full Text] [Related]
26. Prenatal exposure to acid-suppressive drugs and the risk of allergic diseases in the offspring: a cohort study.
Mulder B; Schuiling-Veninga CC; Bos HJ; De Vries TW; Jick SS; Hak E
Clin Exp Allergy; 2014 Feb; 44(2):261-9. PubMed ID: 24164287
[TBL] [Abstract][Full Text] [Related]
27. Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.
Goel GA; Deshpande A; Lopez R; Hall GS; van Duin D; Carey WD
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):422-7. PubMed ID: 22155557
[TBL] [Abstract][Full Text] [Related]
28. An assessment of the association between carvedilol exposure and severe hypersensitivity reactions, angioedema, and anaphylactic reactions: a retrospective nested case-control analysis.
Koro CE; Sowell MD; Stender M
Clin Ther; 2012 Apr; 34(4):870-7. PubMed ID: 22444788
[TBL] [Abstract][Full Text] [Related]
29. Incidence of Clostridium difficile infections in patients receiving antimicrobial and acid-suppression therapy.
King RN; Lager SL
Pharmacotherapy; 2011 Jul; 31(7):642-8. PubMed ID: 21923450
[TBL] [Abstract][Full Text] [Related]
30. Incidence and predictors of cetuximab hypersensitivity reactions in a North Carolina academic medical center.
Hansen NL; Chandiramani DV; Morse MA; Wei D; Hedrick NE; Hansen RA
J Oncol Pharm Pract; 2011 Jun; 17(2):125-30. PubMed ID: 20147576
[TBL] [Abstract][Full Text] [Related]
31. Suspected acute allergic reactions: analysis of admissions to the Emergency Department of the AOU Maggiore della Carità Hospital in Novara from 2003 to 2007.
Dantonio C; Galimberti M; Barbone B; Calamari M; Airoldi G; Campanini M; Di Pietrantonj C; Avanzi GC
Eur Ann Allergy Clin Immunol; 2008 Dec; 40(4):122-9. PubMed ID: 19227647
[TBL] [Abstract][Full Text] [Related]
32. Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry.
Aihara H; Sato A; Takeyasu N; Nishina H; Hoshi T; Akiyama D; Kakefuda Y; Watabe H; Aonuma K;
Catheter Cardiovasc Interv; 2012 Oct; 80(4):556-63. PubMed ID: 22234956
[TBL] [Abstract][Full Text] [Related]
33. Proton pump inhibitors and the risk of acquiring a penicillin allergy label.
Al-Obaydi S; Popadiuk CA; Al-Shaikhly T
Intern Med J; 2023 Aug; 53(8):1481-1484. PubMed ID: 37548300
[TBL] [Abstract][Full Text] [Related]
34. Possible link between history of hypersensitivity to a specific non-steroidal anti-inflammatory drug (NSAID) and positive results following challenge test to alternative NSAIDS.
Trombetta D; Imbesi S; Vita G; Isola S; Minciullo PL; Saija A; Gangemi S
Arzneimittelforschung; 2009; 59(8):410-4. PubMed ID: 19813464
[TBL] [Abstract][Full Text] [Related]
35. Proton pump inhibitors increase significantly the risk of Clostridium difficile infection in a low-endemicity, non-outbreak hospital setting.
Dalton BR; Lye-Maccannell T; Henderson EA; Maccannell DR; Louie TJ
Aliment Pharmacol Ther; 2009 Mar; 29(6):626-34. PubMed ID: 19183143
[TBL] [Abstract][Full Text] [Related]
36. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis.
Janarthanan S; Ditah I; Adler DG; Ehrinpreis MN
Am J Gastroenterol; 2012 Jul; 107(7):1001-10. PubMed ID: 22710578
[TBL] [Abstract][Full Text] [Related]
37. Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites.
Bajaj JS; Zadvornova Y; Heuman DM; Hafeezullah M; Hoffmann RG; Sanyal AJ; Saeian K
Am J Gastroenterol; 2009 May; 104(5):1130-4. PubMed ID: 19337238
[TBL] [Abstract][Full Text] [Related]
38. Proton pump inhibitor use and the antifracture efficacy of alendronate.
Abrahamsen B; Eiken P; Eastell R
Arch Intern Med; 2011 Jun; 171(11):998-1004. PubMed ID: 21321287
[TBL] [Abstract][Full Text] [Related]
39. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
Luk CP; Parsons R; Lee YP; Hughes JD
Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
[TBL] [Abstract][Full Text] [Related]
40. Impact of an antimicrobial allergy label in the medical record on clinical outcomes in hospitalized patients.
Charneski L; Deshpande G; Smith SW
Pharmacotherapy; 2011 Aug; 31(8):742-7. PubMed ID: 21923600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
